π CEPI funds Minapharm's Ebola vaccine trials
CEPI has provided financial backing to Minapharm for its experimental Ebola vaccine development. This support is designated for the vaccine trials being conducted by Minapharm. The funding amounts to up to $16.5 million and is being allocated for the next phase of research. This initiative aims to accelerate the availability of a protective vaccine against Ebola outbreaks. Further updates on the trial progress are expected as the research moves forward. π